SA43-0902 Screening compound: 2-(3,5-dimethyl-1H-pyrazol-1-yl)-1-{6-methyl-7-[3-(pyridin-4-yl)-1,2,4-oxadiazol-5-yl]-2,6-diazaspiro[3.4]octan-2-yl}ethan-1-one

SA43-0902 Screening compound: 2-(3,5-dimethyl-1H-pyrazol-1-yl)-1-{6-methyl-7-[3-(pyridin-4-yl)-1,2,4-oxadiazol-5-yl]-2,6-diazaspiro[3.4]octan-2-yl}ethan-1-one
SA43-0902 Screening compound: 2-(3,5-dimethyl-1H-pyrazol-1-yl)-1-{6-methyl-7-[3-(pyridin-4-yl)-1,2,4-oxadiazol-5-yl]-2,6-diazaspiro[3.4]octan-2-yl}ethan-1-one alternative view

Chemical Structure Depiction of ChemDiv screening compound SA43-0902
2-(3,5-dimethyl-1H-pyrazol-1-yl)-1-{6-methyl-7-[3-(pyridin-4-yl)-1,2,4-oxadiazol-5-yl]-2,6-diazaspiro[3.4]octan-2-yl}ethan-1-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

SA43-0902

Molecular Formula

C21H25N7O2 (C21 H25 N7 O2)

Compound Name

2-(3,5-dimethyl-1H-pyrazol-1-yl)-1-{6-methyl-7-[3-(pyridin-4-yl)-1,2,4-oxadiazol-5-yl]-2,6-diazaspiro[3.4]octan-2-yl}ethan-1-one

IUPAC name

2-(35-dimethyl-1H-pyrazol-1-yl)-1-{6-methyl-7-[3-(pyridin-4-yl)-124-oxadiazol-5-yl]-26-diazaspiro[3.4]octan-2-yl}ethan-1-one

SMILES

Cc1cc(C)nn1CC(N(C1)CC1(C1)CN(C)C1c1nc(-c2ccncc2)no1)=O

InChI

InChI=1S/C21H25N7O2/c1-14-8-15(2)28(24-14)10-18(29)27-12-21(13-27)9-17(26(3)11-21)20-23-19(25-30-20)16-4-6-22-7-5-16/h4-8,17H,9-13H2,1-3H3/t17-/m1/s1

InChI Key

VPNONOVAIKWJOL-QGZVFWFLSA-N

MDL Number (MFCD)

MFCD32236916

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

407.48

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

0.703

Distribution Coefficient, logD

-0.050

Water Solubility, LogSw

-1.14

Polar Surface Area

75.005

Acid Dissociation Constant (pKa)

24.64

Base Dissociation Constant (pKb)

8.07

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

47.62

SA43-0902 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Protein-Protein Interaction Library (218420 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics
Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with SA43-0902 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound SA43-0902?
Check Price and Availability of SA43-0902, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of SA43-0902 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for SA43-0902
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for SA43-0902
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of SA43-0902 available by request